As former Director of the Helmholtz Diabetes Center and the Institute for Diabetes and Obesity at Helmholtz Zentrum Mnchen (20112018) and, since 2018, as CEO of Helmholtz Zentrum Mnchen, he has been responsible for collaborations with a multitude of companies and institutions worldwide
Evidence from murine models demonstrates that SCFA supplementation consistently improves liver health, supporting the therapeutic potential of SCFA-based interventions for human liver disease and warranting clinical investigation (167, 168)
Unlike diet and exercise, and previous therapies that often offered minimal and short-lived weight loss benefits, GLP-1 treatments have proven to be a game-changer
Standard oral capsules face the steepest bioavailability challenge
Depending on what else may be going on life stressors, vacation, change in routine sometimes patients may have no changes in weight or even regain despite medication therapy, she says
User 12 used 500mcg daily and was specifically trying to determine whether splitting that dose or taking it all at once produced better results